An interventional study of Qigong and guidance of nutrition and exercise in Gestational Diabetes Mellitus in Pregnancy, sponsored by Chen Chaoyang. Not yet recruiting. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-07-19.
Sponsored by Chen Chaoyang · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to learn about in women with gestational diabetes's health conditions.
The main question[s] it aims to answer are:
842 studies on the registry are indexed under Diabetes, Gestational; 198 are open to participants now.
This study's planned enrollment of 60 is below the median of 110 across 550 interventional studies indexed under Diabetes, Gestational.
Browse Diabetes, Gestational studies →This is the only study on the registry with Chen Chaoyang as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
On the basis of nutrition and exercise management and guidance, Qigong is exercised. Offline intensive learning once a week, 45-60 minutes each time, study for 12 weeks, and arrange online theory lecture once a week. In addition to concentrated learning, subjects in this group were required to practice themselves at home, at least once a day, each time for 30 minutes.
Other: Qigong
guidance of nutrition and exercise
Behavioral: guidance of nutrition and exercise
An ancient Chinese system of postures, exercises, breathing techniques, and meditations designed to improve and enhance the body's QI.
Provide health promotion and guidance to participants on diet and physical exercise
Fasting blood glucose
If the blood glucose level is between 4.0 and 5.4 mmol/L, the result is normal. If the fasting blood glucose level is between 5.5-6.9 mmol/L, the condition is called prediabetes. Diabetes refers to blood sugar greater than 8.5 mmol/L.
Time frame: Average peripheral fasting blood glucose measured one week prior to participant enrollment. Fasting blood glucose measured in the first week after the end of 12 weeks of intervention.
2-h postprandial plasma glucose
less than 7.8mmol/L. When the blood glucose is 7.8\~11.1 mmol/L 2 hours after meals, it can be diagnosed as impaired or impaired glucose tolerance.
Time frame: Average postprandial blood glucose measured in the week prior to study participant enrollment. Average postprandial 2-hour postprandial peripheral capillary blood glucose measured in the first week after the end of 12 weeks of intervention.
Pittsburgh sleep quality index,PSQI
PSQI was used to measure the sleep quality of participants in the last 1 month. It consists of 19 self-assessment items and 5 other assessment items, of which the 19th self-assessment item and 5 other evaluation items do not participate in scoring, and only 18 self-assessment items participating in scoring are introduced here. 18 items composed of 7 components, each component is scored on a scale of 0-3, the cumulative score of each component is the total score of PSQI, the total score range is 0-2l, the higher the score, the worse the sleep quality.
Time frame: Weeks 0 and 13
Self-Rating Depression Scale，SDS
SDS is rated according to the frequency of symptoms and is divided into 4 levels: no or very little time, a small amount of time, a considerable amount of time, and most or all the time. If it is a positive scoring question, it is rated as a rough score of L, 2, 3, and 4. For reverse grading questions, they are rated as 4, 3, 2, and 1. The assessment time is within the past week, add the scores of each question to a rough score, multiply the rough score by 1.25, and round up the whole number to get the standard score (T). The threshold value of depression assessment is T=53, and the higher the score, the more obvious the tendency to depression.
Time frame: Weeks 0 and 13
Self-Rating Anxiety Scale, SAS
SAS includes 20 items, and the score is based on a standard scoring pattern, with a score of 50 or less being normal, 50-59 being mild anxiety, 60-69 being moderate anxiety, and 70-79 being severe anxiety.
Time frame: Weeks 0 and 13
Maternal and infant complications during childbirth
Time frame: birth
No study locations are listed for this record.
Plan to share: No — This study is still in the exploratory stage and has a certain degree of confidentiality
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.